Literatura académica sobre el tema "Mouth diseases – drug therapy"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Mouth diseases – drug therapy".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Mouth diseases – drug therapy"
Kolesova, V. V., A. M. Lunegov, I. V. Lunegova, V. A. Baryshev y V. M. Matveev. "Comparative pharmacorrection of diseases of the mouth in cats". Legal regulation in veterinary medicine, n.º 4 (8 de enero de 2023): 112–14. http://dx.doi.org/10.52419/issn2782-6252.2022.4.112.
Texto completoГригорьев, С., S. Grigoryev, А. Козьменко y A. Kozmenko. "A new drug for xerostomia combination therapy". Actual problems in dentistry 12, n.º 2 (26 de julio de 2016): 2–10. http://dx.doi.org/10.18481/2077-7566-2016-12-2-2-10.
Texto completoAbdollahi, Mohammad, Mania Radfar y Roja Rahimi. "Current Opinion on Drug-induced Oral Reactions: A Comprehensive Review". Journal of Contemporary Dental Practice 9, n.º 3 (2008): 1–15. http://dx.doi.org/10.5005/jcdp-9-3-1.
Texto completoP R, Meenu y Pradeep K. Kumar. "A REVIEW ON ASCHYOTANA THERAPY AND ITS YOGAS". International Journal of Research in Ayurveda and Pharmacy 12, n.º 4 (28 de agosto de 2021): 146–48. http://dx.doi.org/10.7897/2277-4343.1204124.
Texto completoAditya, Vangara y Kharidhi Laxman Vandana. "Evaluation of Different Local Drug Delivery Systems in Treatment of Periodontitis: An Institutional Study". Journal of Multidisciplinary Dental Research 9, n.º 2 (24 de diciembre de 2023): 67–73. http://dx.doi.org/10.38138/jmdr/v9i2.23.19.
Texto completoDemir, Mehmet Gökhan. "The Effect of Arthrocentesis Treatment for Maximum Mouth Opening and Pain in Temporomandibular Joint Diseases and the Effect of Splint, Drug, and Physical Therapy on This Treatment". Medicina 59, n.º 10 (4 de octubre de 2023): 1767. http://dx.doi.org/10.3390/medicina59101767.
Texto completoVieri, Audrey Amber, Rosiliwati Wihardja y Tenny Setiani Dewi. "Clinical appearance of oral lesions in bronchial asthma patients using inhalation drug". Padjadjaran Journal of Dentistry 32, n.º 3 (30 de noviembre de 2020): 207. http://dx.doi.org/10.24198/pjd.vol32no3.27472.
Texto completoСериков, N. Serikov, Серикова, O. Serikova, Щербаченко y O. Shcherbachenko. "Use of Physiotherapy in the Treatment of Oral Muco-sa (brief message)". Journal of New Medical Technologies 21, n.º 2 (13 de agosto de 2014): 65–68. http://dx.doi.org/10.12737/5001.
Texto completoJayachandran, Abirami Lakshmy, Radhika Katragadda, Ravinder Thyagarajan, Leela Vajravelu, Suganthi Manikesi, Shanmugam Kaliappan y Balaji Jayachandran. "Oral Candidiasis among Cancer Patients Attending a Tertiary Care Hospital in Chennai, South India: An Evaluation of Clinicomycological Association and Antifungal Susceptibility Pattern". Canadian Journal of Infectious Diseases and Medical Microbiology 2016 (2016): 1–6. http://dx.doi.org/10.1155/2016/8758461.
Texto completoAouroud, Hala, Adil Ait Errami, Nayala Hanane Essaidi, FZ Lairani, O. Nacir, Sofia Oubaha, Zouhour Samlani y Khadija Krati. "Compliance to Drug Therapy in Inflammatory Bowel Diseases: A Monocentric Experience". International Journal of Innovative Research in Medical Science 8, n.º 10 (13 de octubre de 2023): 464–68. http://dx.doi.org/10.23958/ijirms/vol08-i10/1763.
Texto completoTesis sobre el tema "Mouth diseases – drug therapy"
Tavari, Mohsen. "Hybrid molecules as inhibitors of the monoamine oxidases and caspase 3 for neurodegenerative disorders". University of the Western Cape, 2016. http://hdl.handle.net/11394/5069.
Texto completoNeurodegenerative diseases are multifactorial in nature, and taking the complex nature of these disorders into consideration, multi-target directed ligands may present as better options to treat these disorders than the classic ‘one molecule, one target’ approach. Neurotransmitter amines are catabolized by monoamine oxidase A and B (MAO-A and MAO-B), therefore they have been targeted for the treatment of neuropsychiatric and neurodegenerative diseases. Besides offering a potential antidepressant action in PD, MAO-A inhibitors may also provide a symptomatic benefit by reducing MAO-A-catalysed oxidation of dopamine. The oxidative deamination reaction catalyzed by MAO-B is one of the major catabolic pathways of dopamine in the brain. Inhibition of this enzyme leads to enhanced dopaminergic neurotransmission and are currently used in the symptomatic treatment of PD. Furthermore, MAO-B inhibitors may also exert neuroprotective effects by reducing the concentration of potentially hazardous by-products produced by MAO-B-catalysed dopamine oxidation. Apoptosis or programmed cell death occurs in a number of neurodegenerative disorders and it has been proven that inhibition of the executing enzyme, caspases-3, slows down or even stops apoptosis. Having this in mind we focused on the propargylamine function of selegiline and the fluorophenyl function of safinamide, because of their inherent monoamine oxidase inhibitory activities; and isatin as a non-peptide inhibitor of caspase-3. Therefore we attempted to design and synthesize multifunctional hybrid molecules acting simultaneously to halt the apoptotic neuronal breakdown process and eliminate the signs and symptoms of diseases such as PD. Seven novel compounds were successfully synthesized utilizing multistep processes. The synthesis of 5 chlorosulfonyl isatin was accomplished starting from the commercially available isatin in two steps, which were, sulfonation using tetramethylene sulfone and chlorination with POCl₃. Next 5-chlorosulfonyl isatin was conjugated to the fluorophenylamine derivative with the fluoro-function at either the ortho, meta or para position through a nucleophilic substitution reaction on the chlorosulfonyl position. The resultant compounds were coupled on the N position of the isatin function with propargyl bromide, using a microwave synthesis procedure, in a nucleophilic substitution reaction. The structures and purity were confirmed by nuclear magnetic resonance (NMR) and mass spectrometry (MS). In the biological evaluations recombinant human MAO-A, MAO-B and caspase 3 enzymatic assays were performed to determine the activity of the novel compounds at an enzymatic level. The inhibition percentages for these compounds were calculated and plotted against the logarithm 8 of the inhibitor concentrations to obtain a sigmoidal dose-response curve and consequently the IC50 value. The synthesized compounds showed inhibition of the MAO-A, MAO-B and caspase-3 enzymes at low to high micro molar concentrations. The role of the fluorophenylamine moiety in the synthesized compounds was significant for their multifunctional activity as shown by compounds 3 and 4 having good inhibitory activity towards MAO-A, MAO-B and also excellent inhibitory activity against caspase 3, making those ideal candidates for further lead compound development and multifunctional drug design. The introduction of the propargylamine moiety only increased the MAO-A inhibitory activity; this was shown by compounds 7, 8 and 9 which exhibit good MAO-A selectivity with low MAO-B and caspase-3 inhibitory activities.
Zent, Clive Steven y Clive Steven Zent. "The use of aminoglycoside antibiotic therapy in neutropaenic patients with haematological disease". Master's thesis, University of Cape Town, 1991. http://hdl.handle.net/11427/24969.
Texto completoThomson, William Murray. "Medications, dry mouth and dental caries among older people : a longitudinal study /". Title page, contents and abstract only, 1999. http://web4.library.adelaide.edu.au/theses/09PH/09pht4858.pdf.
Texto completoYu, Zhen. "Altered drug responses in diabetic and hypertensive-diabetic cardiomyopathy". Thesis, University of British Columbia, 1990. http://hdl.handle.net/2429/29406.
Texto completoPharmaceutical Sciences, Faculty of
Graduate
Flood, Lars. "Glucocorticosteroid therapy and steroid resistance in inflammatory bowel disease /". Stockholm, 2004. http://diss.kib.ki.se/2004/91-7140-020-6/.
Texto completoKucukturhan, Aysu. "Bioactive Agent Carrying Plga Nanoparticles In Thetreatment Of Skin Diseases". Master's thesis, METU, 2012. http://etd.lib.metu.edu.tr/upload/12614551/index.pdf.
Texto completo1.5%. L929 fibroblast and Saos 2 human osteosarcoma cells were used to study the uptake of NPs by the cells. Particles accumulate near the nucleus. The characterization and cell viability tests, and drug release behavior indicate the suitability of these NPs for further testing to develop a patient specific skin diseases treatment approach.
Törneke, Karolina. "Pharmacological aspects of adrenoceptor drugs in the horse /". Uppsala : Swedish Univ. of Agricultural Sciences (Sveriges lantbruksuniv.), 1999. http://epsilon.slu.se/avh/1999/91-576-5431-X.pdf.
Texto completoCameli, Paolo. "The impact of antifibrotic therapy in the management of idiopathic pulmonary fibrosis and progressive fibrosing interstitial lung diseases: a real-world comparative study of efficacy between pirfenidone and nintedanib". Doctoral thesis, Università di Siena, 2021. http://hdl.handle.net/11365/1159047.
Texto completoWang, Jianghai. "Human deoxyribonucleoside kinases : their substrate recognition and implications for chemotherapy /". Uppsala : Swedish Univ. of Agricultural Sciences (Sveriges lantbruksuniv.), 1999. http://epsilon.slu.se/avh/1999/91-576-5427-1.pdf.
Texto completoHorn, Je'nine. "The analysis of 6- and 24-hour iodine-131 thyroid uptake in patients with Graves' disease at Universitas Hospital". Thesis, [Bloemfontein?] : Central University of Technology, Free State, 2007. http://hdl.handle.net/11462/102.
Texto completoIn the South African Health Services (SAHS) it is each health worker’s responsibility to find ways to reduce health care cost and improve health service to the public. The measurement of radioactive iodine uptake (RAIU) by the thyroid gland for diagnostic purposes has been used as early as the 1940s. The 24-hour (hr) iodine-131 (131I) uptake measurement is traditionally used for the calculation of the 131I administered activity for therapy dosage. This entails that the patient’s hospitalisation is prolonged, which increases the costs. The literature also indicates that the 24-hr 131I uptake value can be discarded and only the 6-hr 131I uptake measurement is needed to calculate administered activity for therapeutic dosages for Graves’ patients. Therefore, if it can be confirmed that the 6-hr 131I uptake measurement alone is needed, the SAHS could decrease hospitalisation costs. The overall goal of the investigation was to analyse the 6-hr and 24-hr 131I uptake measurements of patients with Graves’ disease at the Universitas Hospital. The aim was to determine the relationship between the 6-hr and 24- hr RAIU values to establish the therapeutic dosage for Graves’ disease. To achieve the aim, three objectives were set. First, to serve as a background to the investigation, a literature survey relating to the RAIU measurements of patients with Graves’ disease was made. Second, a retrospective analysis was performed by collecting the 6-hr and 24-hr 131I uptake measurements of patients with proven Graves’ disease at the Universitas Nuclear Medicine Department (UNMD). Finally, the data obtained from the retrospective analysis was analysed, summarised and compared to answer the investigation questions. The investigation group included patients with confirmed Graves’ disease who had undergone both the 6- and 24-hr 131I RAIU at the Universitas Hospital from the beginning of 2004 to the end of 2005. Graves’ disease is confirmed by the following factors at the UNMD, namely: Suppressed TSH, elevated T4 and T3 values, an increased uptake on the 99mTc-pertechnetate scan and increased 6- and 24-hr 131I RAIU values. The UNMD statistics show that 178 patients were diagnosed with Graves’ disease during this period. The patients of the investigation group included both male and female patients from different races, ranging from 15-75 years. In order to increase the validity of the investigation, all factors that could influence the accuracy of the 131I thyroid uptake test were excluded. After the exclusion and inclusion criteria had been applied, the final investigation group was made up of 124 Graves’ disease patients. The data obtained from the patient files was noted on the different data sheets (see Appendix A) for further analysis. The information from these data sheets was then used to obtain the investigation results. The Department of Biostatistics of the University of the Free State (UFS) was consulted for recommendations regarding the management of data and the processing of results. All values were summarised by means and Standard Deviations (SD) or percentiles. Mean or median differences were calculated with a 95% Confidence Interval (CI). A regression analysis was made between the 6-hr and 24-hr 131I RAIU values. The highest RAIU value is the best to calculate the therapeutic dosage, as this gives a true reflection of the thyroid function of a Graves’ disease patient. In the investigation group the median of the 24-hr 131I RAIU values was higher than the 6-hr 131I RAIU values. The findings showed that the 24-hr 131I RAIU in most of the investigation group was the highest value and most effective to calculate the 131I therapeutic dosage. At a time when research-based practice is taking on an increasingly important role, it is essential for nuclear medicine departments to make evidence-based recommendations. This investigation found that the correlation between the 6-hr and 24-hr RAIU clearly justified the cost spent on Graves’ disease patients who must stay overnight for the 24-hr 131I RAIU procedure.
Libros sobre el tema "Mouth diseases – drug therapy"
Robert, Newland J., ed. Oral soft tissue diseases: A reference manual for diagnosis & management. Hudson, Ohio: Lexi-Comp, 2001.
Buscar texto completoNewland, J. Robert. Oral hard tissue diseases: A reference manual for radiographic diagnosis. 3a ed. Hudson, Ohio: Lexi-Comp, 2012.
Buscar texto completoZambito, Raymond F. Immunology and infectious diseases of the mouth, head, and neck. St. Louis: Mosby Year Book, 1991.
Buscar texto completoSeymour, R. A. Adverse drug reactions in dentistry. 2a ed. Oxford: Oxford University Press, 1996.
Buscar texto completoSeymour, R. A. Adverse drug reactions in dentistry. Oxford: Oxford University Press, 1988.
Buscar texto completoH, Messerli Franz, ed. Cardiovascular drug therapy. 2a ed. Philadelphia: Saunders, 1996.
Buscar texto completoKhan, M. Gabriel. Cardiac drug therapy. 3a ed. London: W.B. Sanders, 1992.
Buscar texto completoJ, Eadie Mervyn, ed. Drug therapy in neurology. Edinburgh: Churchill Livingstone, 1992.
Buscar texto completoCorporation, Springhouse, ed. Cardiovascular drug therapy. Springhouse, Pa: Springhouse Corp., 1995.
Buscar texto completoKhan, M. I. Gabriel. Manual of cardiac drug therapy. 2a ed. London: Bailliere Tindall, 1988.
Buscar texto completoCapítulos de libros sobre el tema "Mouth diseases – drug therapy"
Merk, Hans F. y Daniela Höller Obrigkeit. "Drug Reactions". En Therapy of Skin Diseases, 297–319. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-78814-0_29.
Texto completoWehling, Martin. "Obstructive Lung Diseases". En Drug Therapy for the Elderly, 135–42. Vienna: Springer Vienna, 2012. http://dx.doi.org/10.1007/978-3-7091-0912-0_11.
Texto completoWu, Gencheng, Yanqing Wang y Xiaoding Cao. "Acupuncture-Drug Balanced Anesthesia". En Acupuncture Therapy for Neurological Diseases, 143–61. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-642-10857-0_6.
Texto completoSepúlveda, Maria, Albert Saiz y Francesc Graus. "Targeting B Cells in Neurological Autoimmune Diseases". En Milestones in Drug Therapy, 219–46. Basel: Springer Basel, 2013. http://dx.doi.org/10.1007/978-3-0348-0706-7_12.
Texto completoBosch, Xavier, Pilar Brito-Zerón, Munther A. Khamashta y Manuel Ramos-Casals. "Targeting B Cells in Other Systemic Autoimmune Diseases". En Milestones in Drug Therapy, 247–58. Basel: Springer Basel, 2013. http://dx.doi.org/10.1007/978-3-0348-0706-7_13.
Texto completoLaird, Glen. "Introduction to Rare Disease Therapy Development". En Drug Development for Rare Diseases, 1–6. Boca Raton: Chapman and Hall/CRC, 2023. http://dx.doi.org/10.1201/9781003080954-1.
Texto completoFeng, Yi y Boying Chen. "Effect of Acupuncture on Drug Addiction". En Acupuncture Therapy for Neurological Diseases, 460–72. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-642-10857-0_18.
Texto completoChow, Shein-Chung. "Gene Therapy for Rare Diseases". En Innovative Methods for Rare Disease Drug Development, 247–64. Boca Raton, FL : CRC Press, 2021. |: Chapman and Hall/CRC, 2020. http://dx.doi.org/10.1201/9781003049364-13.
Texto completoWinchester, James F. "Acute Drug Intoxications". En Therapy of Renal Diseases and Related Disorders, 639–48. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4613-0689-4_40.
Texto completoRobinson, Peter. "Cell and Gene Therapy in Rare Diseases". En Rare Disease Drug Development, 249–61. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-78605-2_16.
Texto completoActas de conferencias sobre el tema "Mouth diseases – drug therapy"
Silveira, Rayanne Maria Brandão da, Marcela Marques de Oliveira Gregório, Elza Marcia Targar Yacubian y Laura Maria de Figueiredo Ferreira Guilhoto. "Cardiovascular risk in adults with drug-resistant epilepsy submitted to the modified atkins diet". En XIV Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2023. http://dx.doi.org/10.5327/1516-3180.141s1.728.
Texto completoThomas, E. y F. Blotman. "SP0064 Drug therapy in fibromyalgia. a review". En Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.20.
Texto completoХИЗРИЕВ, М. Д., И. Э. АТАШЕВА y З. О. ГАРУНОВ. "Drug therapy of patients with stable angina pectoris". En II Международная научно-практическая конференция "Преобразование современного мира: проблемы и возможности". Crossref, 2024. http://dx.doi.org/10.26118/5186.2024.80.69.007.
Texto completoBorges, Érico Induzzi, André Lopez Fernandez, Louis Fernando Marques de Almeida, Juline do Prado Paes, Jandey da Glória Bigonha, Antônio José da Rocha, Herval Soares Ribeiro Neto y Sônia Maria Cesar de Azevedo Silva. "Progressive Multifocal Leukoencephalopathy following Daratumumab therapy for refractory Multiple Myeloma – a case report". En XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.441.
Texto completoCheung, S., F. Kudaeva, P. Heidari y D. Truong. "AB1665-PARE DRUG PERSISTENCE WITH THERAPY OF ADALIMUMAB BIOSIMILAR, MSB11022, IN RHEUMATOLOGIC DISEASES". En EULAR 2024 European Congress of Rheumatology, 12-15 June. Vienna, Austria. BMJ Publishing Group Ltd and European League Against Rheumatism, 2024. http://dx.doi.org/10.1136/annrheumdis-2024-eular.5499.
Texto completoBarzizza, F., G. Belloni, E. Trespi, A. Venturini y I. Richichi. "HYPOGLYCEMIC EFFECT OF INDOBUFEN,AN ANTIAGGREGATING AGENT,IN ELDERLY DIABETIC PATIENTS". En XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643100.
Texto completoKim, Jinho y Jim S. Chen. "Effect of Inhaling Patterns on Aerosol Drug Delivery: CFD Simulation". En ASME 2008 International Mechanical Engineering Congress and Exposition. ASMEDC, 2008. http://dx.doi.org/10.1115/imece2008-66685.
Texto completoOkun', Dmitriy. "FORMAL REPRESENTATION OF KNOWLEDGE ABOUT MEDICAMENTAL THERAPY FOR ISCHEMIC HEART DISEASES (detail)". En XIV International Scientific Conference "System Analysis in Medicine". Far Eastern Scientific Center of Physiology and Pathology of Respiration, 2020. http://dx.doi.org/10.12737/conferencearticle_5fe01d9bce39f8.78028503.
Texto completoCanzian, Kássia Braga, Marcella Canato Toloi, David Vargas Freitas Teixeira, Vanessa de Freitas Moreira, Amanda Freitas Alves, Eric Dupont, Fernanda Maria Gonçalves de Sousa Moura, Isabela de Almeida Stella, Thiago Ivan Vilchez Santillan y Herval Ribeiro Soares Neto. "Chronic paraneoplastic polyradiculoneuropathy during colorectal cancer: a case report". En XIV Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2023. http://dx.doi.org/10.5327/1516-3180.141s1.633.
Texto completoSheenkova, M. V. "ON THE PATHOGENESIS OF GASTRODUODENAL ZONE LESIONS IN VARIOUS VARIANTS OF DRUG THERAPY FOR OCCUPATIONAL RESPIRATORY DISEASES". En The 16th «OCCUPATION and HEALTH» Russian National Congress with International Participation (OHRNC-2021). FSBSI “IRIOH”, 2021. http://dx.doi.org/10.31089/978-5-6042929-2-1-2021-1-575-578.
Texto completoInformes sobre el tema "Mouth diseases – drug therapy"
Grueso-Navarro, Elena, Leticia Rodríguez-Alcolado, Ángel Arias, Emilio J. Laserna-Mendieta y Alfredo J. Lucendo. Influence of HLA-DQA1*05 allele in the response to anti-TNFα drugs in inflammatory bowel diseases. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, febrero de 2023. http://dx.doi.org/10.37766/inplasy2023.2.0076.
Texto completoLI, jianhong, Zhuang LI, Yalin SHE y Guohua LIN. Assessment of acupuncture for treating herpes zoster:a protocol for an umbrella systematic review and meta analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, abril de 2022. http://dx.doi.org/10.37766/inplasy2022.4.0010.
Texto completoTang, Jiqin, Gong Zhang, Jinxiao Xing, Ying Yu y Tao Han. Network Meta-analysis of Heat-clearing and Detoxifying Oral Liquid of Chinese Medicines in Treatment of Children’s Hand-foot-mouth Disease:a protocol for systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, enero de 2022. http://dx.doi.org/10.37766/inplasy2022.1.0032.
Texto completo